Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Form of Placement Agent Agreement
- 4.3 Form of Pre-funded Warrant
- 4.4 Form of Common Warrant
- 10.55 Form of Securities Purchase Agreement
- 10.56 Form of Lock-up Agreement
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
Associated filings
- 25 Apr 24 EFFECT Notice of effectiveness
- 19 Apr 24 POS AM Prospectus update (post-effective amendment)
- 28 Feb 24 424B3 Prospectus supplement
- 16 Feb 24 424B3 Prospectus supplement
- 30 Nov 23 424B3 Prospectus supplement
- 15 Aug 23 424B3 Prospectus supplement
- 11 Aug 23 424B4 Prospectus supplement with pricing info
- 10 Aug 23 EFFECT Notice of effectiveness
- 25 Jul 23 S-1/A IPO registration (amended)
-
16 Jun 23 S-1 IPO registration
ATNF similar filings
Filing view
External links
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of 180 Life Sciences Corp. on Form S-1 of our report dated March 31, 2023, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of 180 Life Sciences Corp. as of December 31, 2022, and 2021 and for each of the two years in the period ended December 31, 2022, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum llp
Marcum llp
San Francisco, CA
June 16, 2023